Top Markets
#1 MowCat MowCat +781.41%
#2 Islamic Coin Islamic Coin +152.09%
#3 龙虾 (Lobster) 龙虾 (Lobster) +85.82%
#4 Akedo Akedo +57.05%
#5 Magma Finance Magma Finance +42.91%
#6 MarsCoin MarsCoin +32.74%
#7 Pons Pons +32.28%
#8 SIXSEVEN SIXSEVEN +30.44%
#9 DeXe DeXe +27.75%
#10 Cortex Cortex +26.60%
Coin of the day
MowCat MowCat
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
LB Pharmaceuticals Inc Common Stock LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

LBRX
Rang in Aktien #8002
This biopharmaceutical firm is currently in the clinical development stage,... This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
Aktienkurs
$48.45
Marktkapitalisierung
$1.39B
Veränderung (1 Tag)
1.16%
Veränderung (1 Jahr)
-
Land
US
Handel LB Pharmaceuticals Inc Common Stock (LBRX)

Kategorie

Healthcare
Dividendenrendite-Verlauf für LB Pharmaceuticals Inc Common Stock (LBRX)
Dividendenrendite (TTM) von LB Pharmaceuticals Inc Common Stock (Aktienkürzel: LBRX) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für LB Pharmaceuticals Inc Common Stock (LBRX) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH